Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report

Primary squamous cell carcinoma of the breast is a rare subtype of carcinoma of chemosis for which there is no effective chemotherapy regimen. Breast squamous cell carcinoma is usually “triple negative”, with poor chemotherapy effects and poor prognosis. Here, we report a successful case of primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Fangfang, Li, Jingtai, Liao, Haoran, Fan, Pingming, Wang, Minjian, Liu, Yu, Ding, Linwei, Du, Guankui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213914/
https://www.ncbi.nlm.nih.gov/pubmed/37251309
http://dx.doi.org/10.3389/fphar.2023.1115422
_version_ 1785047727732686848
author Gao, Fangfang
Li, Jingtai
Liao, Haoran
Fan, Pingming
Wang, Minjian
Liu, Yu
Ding, Linwei
Du, Guankui
author_facet Gao, Fangfang
Li, Jingtai
Liao, Haoran
Fan, Pingming
Wang, Minjian
Liu, Yu
Ding, Linwei
Du, Guankui
author_sort Gao, Fangfang
collection PubMed
description Primary squamous cell carcinoma of the breast is a rare subtype of carcinoma of chemosis for which there is no effective chemotherapy regimen. Breast squamous cell carcinoma is usually “triple negative”, with poor chemotherapy effects and poor prognosis. Here, we report a successful case of primary breast squamous cell carcinoma treated with apatinib. The patient was treated with 2 cycles of apatinib. The efficacy was evaluated as partial remission, and a sublesion of approximately 4 cm fell off.
format Online
Article
Text
id pubmed-10213914
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102139142023-05-27 Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report Gao, Fangfang Li, Jingtai Liao, Haoran Fan, Pingming Wang, Minjian Liu, Yu Ding, Linwei Du, Guankui Front Pharmacol Pharmacology Primary squamous cell carcinoma of the breast is a rare subtype of carcinoma of chemosis for which there is no effective chemotherapy regimen. Breast squamous cell carcinoma is usually “triple negative”, with poor chemotherapy effects and poor prognosis. Here, we report a successful case of primary breast squamous cell carcinoma treated with apatinib. The patient was treated with 2 cycles of apatinib. The efficacy was evaluated as partial remission, and a sublesion of approximately 4 cm fell off. Frontiers Media S.A. 2023-05-11 /pmc/articles/PMC10213914/ /pubmed/37251309 http://dx.doi.org/10.3389/fphar.2023.1115422 Text en Copyright © 2023 Gao, Li, Liao, Fan, Wang, Liu, Ding and Du. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Gao, Fangfang
Li, Jingtai
Liao, Haoran
Fan, Pingming
Wang, Minjian
Liu, Yu
Ding, Linwei
Du, Guankui
Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report
title Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report
title_full Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report
title_fullStr Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report
title_full_unstemmed Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report
title_short Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report
title_sort case report: apatinib combined with neoadjuvant therapy for primary squamous cell carcinoma of the breast: a case report
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213914/
https://www.ncbi.nlm.nih.gov/pubmed/37251309
http://dx.doi.org/10.3389/fphar.2023.1115422
work_keys_str_mv AT gaofangfang casereportapatinibcombinedwithneoadjuvanttherapyforprimarysquamouscellcarcinomaofthebreastacasereport
AT lijingtai casereportapatinibcombinedwithneoadjuvanttherapyforprimarysquamouscellcarcinomaofthebreastacasereport
AT liaohaoran casereportapatinibcombinedwithneoadjuvanttherapyforprimarysquamouscellcarcinomaofthebreastacasereport
AT fanpingming casereportapatinibcombinedwithneoadjuvanttherapyforprimarysquamouscellcarcinomaofthebreastacasereport
AT wangminjian casereportapatinibcombinedwithneoadjuvanttherapyforprimarysquamouscellcarcinomaofthebreastacasereport
AT liuyu casereportapatinibcombinedwithneoadjuvanttherapyforprimarysquamouscellcarcinomaofthebreastacasereport
AT dinglinwei casereportapatinibcombinedwithneoadjuvanttherapyforprimarysquamouscellcarcinomaofthebreastacasereport
AT duguankui casereportapatinibcombinedwithneoadjuvanttherapyforprimarysquamouscellcarcinomaofthebreastacasereport

Ejemplares similares